Document is current
Any future updates will be listed below
-
Authors
Huber, Veronica https://orcid.org/0000-0001-6304-3575
Di Guardo, Lorenza
Lalli, Luca
Giardiello, Daniele
Cova, Agata
Squarcina, Paola
Frati, Paola
Di Giacomo, Anna Maria
Pilla, Lorenzo
Tazzari, Marcella https://orcid.org/0000-0002-8112-1773
Camisaschi, Chiara
Arienti, Flavio
Castelli, Chiara
Rodolfo, Monica
Beretta, Valeria
Di Nicola, Massimo
Maio, Michele
Del Vecchio, Michele
de Braud, Filippo
Mariani, Luigi
Rivoltini, Licia
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct01307397 at ClinicalTrials.govnct01307397 at ClinicalTrials.govDocuments that mention this clinical trial
Back to simplicity: a four-marker blood cell score to quantify prognostically relevant myeloid cells in melanoma patients
https://doi.org/10.1136/jitc-2020-001167
Documents that mention this clinical trial
Back to simplicity: a four-marker blood cell score to quantify prognostically relevant myeloid cells in melanoma patients
https://doi.org/10.1136/jitc-2020-001167
-
Funding
Funding for this research was provided by:
Horizon 2020 Framework Programme (Research and Innovation Programme no. 686089)
Associazione Italiana per la Ricerca sul Cancro (5X1000 no. 12162 to LR)
Associazione Italiana per la Ricerca sul Cancro (Investigator grant IG20752 to LR)
Associazione Italiana per la Ricerca sul Cancro (Investigator grant IG15373 to MM)
TRANSCAN2 ERANET (ER-2017-2364968 - TRS-2016-00000393 CE (JTC 2015))
- License Information
